A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives

References

• Guariguata L , Whiting DR , Hambleton I , Beagley J , Linnenkamp U , Shaw JE . Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract . 2014;103(2):137–149. doi:10.1016/j.diabres.2013.11.002 24630390
   PubMed Web of Science ®Google Scholar
• Ozougwu JC , Obimba KC , Belonwu CD , Unakalamba CB . The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol . 2013;4:46–57. doi:10.5897/JPAP2013.0001
   Google Scholar
• Thompson A , Kanamarlapudi V . Type 2 Diabetes mellitus and glucagon like peptide-1 receptor signalling. Clin Exp Pharmacol . 2013;1:3.
   Google Scholar
• Maahs DM , West NA , Lawrence JM , Mayer-Davis EJ . Chapter 1: epidemiology of Type 1 Diabetes. Endocrinol Metab Clin North Am . 2010;39(3):481–497. doi:10.1016/j.ecl.2010.05.011 20723815
   PubMed Web of Science ®Google Scholar
• Kahn SE , Cooper ME , Del Prato S . Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet . 2014;383(9922):1068–1083. doi:10.1016/S0140-6736(13)62154-6 24315620
   PubMed Web of Science ®Google Scholar
• Leahy JL . Pathogenesis of Type 2 Diabetes Mellitus. Arch Med Res . 2005;36(3):197–209. doi:10.1016/j.arcmed.2005.01.003 15925010
   PubMed Web of Science ®Google Scholar
• Chen L , Magliano DJ , Zimmet PZ . The worldwide epidemiology of type 2 diabetes mellitus[mdash]present and future perspectives. Nat Rev Endocrinol . 2012;8(4):228–236. doi:10.1038/nrendo.2011.183
   Web of Science ®Google Scholar
• Raz I . Guideline approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care . 2013;36(Suppl 2):S139–S144. doi:10.2337/dcS13-2035 23882038
   PubMed Web of Science ®Google Scholar
• Golay A , Ybarra J . Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab . 2005;19(4):649–663. doi:10.1016/j.beem.2005.07.010 16311223
   PubMed Web of Science ®Google Scholar
• Haslam D . Obesity and diabetes: the links and common approaches. Prim Care Diabetes . 2010;4(2):105–112. doi:10.1016/j.pcd.2010.04.002 20447884
   PubMed Web of Science ®Google Scholar
• Horton ES , Silberman C , Davis KL , Berria R . Weight Loss, Glycemic Control, and Changes in Cardiovascular Biomarkers in Patients With Type 2 Diabetes Receiving Incretin Therapies or Insulin in a Large Cohort Database. Diabetes Care . 2010;33(8):1759–1765. doi:10.2337/dc09-2062 20460445
   PubMed Web of Science ®Google Scholar
• Wilding JPH . The importance of weight management in type 2 diabetes mellitus. Int J Clin Pract . 2014;68(6):682–691. doi:10.1111/ijcp.12384 24548654
   PubMed Web of Science ®Google Scholar
• Fujioka K . Follow-up of nutritional and metabolic problems after bariatric surgery. Diabetes Care . 2005;28(2):481–484. doi:10.2337/diacare.28.2.481 15677821
   PubMed Web of Science ®Google Scholar
• Thompson A , Stephens JW , Bain SC , Kanamarlapudi V . Molecular characterisation of small molecule agonists effect on the human glucagon like peptide-1 receptor internalisation. PLoS One . 2016;11(4):e0154229–e0154229. doi:10.1371/journal.pone.0154229 27100083
   PubMed Web of Science ®Google Scholar
• Kyrou IRH , Weickert MO . Clinical Problems Caused by Obesity . South Dartmouth: Endotext; 2010.
   Google Scholar
• Nguyen DM , El-Serag HB . The Epidemiology of Obesity. Gastroenterol Clin North Am . 2010;39(1):1–7. doi:10.1016/j.gtc.2009.12.014 20202574
   PubMed Web of Science ®Google Scholar
• Paz-Filho G , Mastronardi C , Delibasi T , Wong M-L , Licinio J . Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy. Arq Bras Endocrinol Metabol . 2010;54(8):690–697. doi:10.1590/S0004-27302010000800005 21340154
   PubMedGoogle Scholar
• WHO. Obesity and overweight; 2014. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed 7 12, 2021.
   Google Scholar
• Malnick SDH , Knobler H . The medical complications of obesity. QJM . 2006;99(9):565–579. doi:10.1093/qjmed/hcl085 16916862
   PubMed Web of Science ®Google Scholar
• Must A . The Disease Burden Associated with Overweight and Obesity . South Dartmouth: Endotext; 2012.
   Google Scholar
• Bagdade JD , Bierman EL , Porte D . The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest . 1967;46(10):1549–1557. doi:10.1172/JCI105646 6061732
   PubMed Web of Science ®Google Scholar
• Ferrannini E , Natali A , Bell P , Cavallo-Perin P , Lalic N , Mingrone G . Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest . 1997;100(5):1166–1173. doi:10.1172/JCI119628 9303923
   PubMed Web of Science ®Google Scholar
• Gerald R . All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diabetes Vascular Dis Res . 2005;2(3):105–112. doi:10.3132/dvdr.2005.017
   Google Scholar
• Templeman NM , Skovsø S , Page MM , Lim GE , Johnson JD . A causal role for hyperinsulinemia in obesity. J Endocrinol . 2017;2017:58.
   Google Scholar
• Weng J , Ji L , Jia W , et al. Standards of care for type 2 diabetes in China. Diabetes Metab Res Rev . 2016;32(5):442–458. doi:10.1002/dmrr.2827 27464265
   PubMed Web of Science ®Google Scholar
• Hegazi R , El-Gamal M , Abdel-Hady N , Hamdy O . Epidemiology of and risk factors for type 2 diabetes in egypt. Ann Global Health . 2015;81(6):814–820. doi:10.1016/j.aogh.2015.12.011
   PubMed Web of Science ®Google Scholar
• Wild SH , Byrne CD . Commentary: sub-types of diabetes—what’s new and what’s not. Int J Epidemiol . 2013;42(6):1600–1602. doi:10.1093/ije/dyt201 24415600
   PubMed Web of Science ®Google Scholar
• Hu FB . Globalization of Diabetes. Role Diet Lifestyle Genes . 2011;34(6):1249–1257.
   Google Scholar
• D’Alessio D . The role of dysregulated glucagon secretion in type 2 diabetes. Diabetes Obes Metab . 2011;13:126–132. doi:10.1111/j.1463-1326.2011.01449.x 21824266
   PubMed Web of Science ®Google Scholar
• Lin Y , Sun Z . Current views on type 2 diabetes. J Endocrinol . 2010;204(1):1. doi:10.1677/JOE-09-0260 19770178
   PubMed Web of Science ®Google Scholar
• Okon EB , Chung AWY , Zhang H , Laher I , van Breemen C . Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes. Can J Physiol Pharmacol . 2007;85(5):562–567. doi:10.1139/Y07-026 17632592
   PubMed Web of Science ®Google Scholar
• Voet D , Voet J . Biochemistry . 4th ed. New York: Wiley & Sons; 2011.
   Google Scholar
• Whitmore C . Type 2 diabetes and obesity in adults. Br J Nursing . 2010;19(14):880–886. doi:10.12968/bjon.2010.19.14.49041
   Google Scholar
• Zhou X , Ji L , Ran X , et al. Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: an Analysis of the Nationwide, Cross-Sectional 3B Study. PLoS One . 2016;11(1):e0144179. doi:10.1371/journal.pone.0144179 26726883
   PubMed Web of Science ®Google Scholar
• Mathews AEW , Mathews CE . Inherited β-Cell Dysfunction in Lean Individuals With Type 2 Diabetes. Diabetes . 2012;61(7):1659–1660. doi:10.2337/db12-0373 22723272
   PubMed Web of Science ®Google Scholar
• Ali O . Genetics of type 2 diabetes. World J Diabetes . 2013;4(4):114–123. doi:10.4239/wjd.v4.i4.114 23961321
   PubMedGoogle Scholar
• Prasad RB , Groop L . Genetics of Type 2 Diabetes—Pitfalls and Possibilities. Genes . 2015;6(1):87–123. doi:10.3390/genes6010087 25774817
   PubMed Web of Science ®Google Scholar
• Faerch KHA , Solomon TP . Heterogeneity of Pre-diabetes and Type 2 Diabetes: implications for Prediction, Prevention and Treatment Responsiveness. Curr Diabetes Rev . 2016;12:30–41. doi:10.2174/1573399811666150416122903 25877695
   PubMedGoogle Scholar
• Karalliedde J , Gnudi L . Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dialysis Transplant . 2016;31(2):206–213.
   PubMed Web of Science ®Google Scholar
• Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature . 2001;414(6865):813–820. doi:10.1038/414813a 11742414
   PubMed Web of Science ®Google Scholar
• Holman N , Young RJ , Jeffcoate WJ . Variation in the recorded incidence of amputation of the lower limb in England. Diabetologia . 2012;55(7):1919–1925. doi:10.1007/s00125-012-2468-6 22398645
   PubMed Web of Science ®Google Scholar
• Akter K , Lanza EA , Martin SA , Myronyuk N , Rua M , Raffa RB . Diabetes mellitus and Alzheimer’s disease: shared pathology and treatment? Br J Clin Pharmacol . 2011;71(3):365–376. doi:10.1111/j.1365-2125.2010.03830.x 21284695
   PubMed Web of Science ®Google Scholar
• Hu G , Jousilahti P , Bidel S , Antikainen R , Tuomilehto J . Type 2 Diabetes and the Risk of Parkinson’s Disease. Diabetes Care . 2007;30(4):842–847. doi:10.2337/dc06-2011 17251276
   PubMed Web of Science ®Google Scholar
• Ali MK , Narayan V , Tandon N . Diabetes & coronary heart disease: current perspectives. Indian J Med Res . 2010;132(5):584–597.21150011
   PubMed Web of Science ®Google Scholar
• Leal J , Gray AM , Clarke PM . Development of life-expectancy tables for people with type 2 diabetes. Eur Heart J . 2009;30(7):834–839. doi:10.1093/eurheartj/ehn567 19109355
   PubMed Web of Science ®Google Scholar
• Mazzola N . Review of current and emerging therapies in type 2 diabetes mellitus. Am J Manag Care . 2012;18:17–26.22435745
   PubMed Web of Science ®Google Scholar
• Olokoba AB , Obateru OA , Olokoba LB . Type 2 Diabetes Mellitus: a Review of Current Trends. Oman Med J . 2012;27(4):269–273. doi:10.5001/omj.2012.68 23071876
   PubMedGoogle Scholar
• Amiel SA , Dixon T , Mann R , Jameson K . Hypoglycaemia in Type 2 diabetes. Diabetic Med . 2008;25(3):245–254. doi:10.1111/j.1464-5491.2007.02341.x 18215172
   PubMed Web of Science ®Google Scholar
• Fonseca VA . Defining and Characterizing the Progression of Type 2 Diabetes. Diabetes Care . 2009;32(Suppl 2):S151–S156. doi:10.2337/dc09-S301 19875543
   PubMed Web of Science ®Google Scholar
• Leibowitz G , Kaiser N , Cerasi E . β‐Cell failure in type 2 diabetes. J Diabetes Investig . 2011;2(2):82–91. doi:10.1111/j.2040-1124.2010.00094.x
   Web of Science ®Google Scholar
• Forbes JM , Cooper ME . Mechanisms of Diabetic Complications. Physiol Rev . 2013;93(1):137–188. doi:10.1152/physrev.00045.2011 23303908
   PubMed Web of Science ®Google Scholar
• Bhurosy T , Jeewon R . Overweight and Obesity Epidemic in Developing Countries: a Problem with Diet, Physical Activity, or Socioeconomic Status? Scientific World J . 2014;2014:7. doi:10.1155/2014/964236
   Google Scholar
• Shaw JE , Sicree RA , Zimmet PZ . Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract . 2010;87(1):4–14. doi:10.1016/j.diabres.2009.10.007 19896746
   PubMed Web of Science ®Google Scholar
• Onge ES , Miller SA , Motycka C , DeBerry A . A review of the treatment of type 2 diabetes in children. J Pediatric Pharmacol Therapeutics . 2015;20(1):4–16. doi:10.5863/1551-6776-20.1.4
   Google Scholar
• Reinehr T . Type 2 diabetes mellitus in children and adolescents. World J Diabetes . 2013;4(6):270–281. doi:10.4239/wjd.v4.i6.270 24379917
   PubMedGoogle Scholar
• Atkinson MA . The pathogenesis and natural history of type 1 diabetes. Cold Spring Harb Perspect Med . 2012;2(11):a007641. doi:10.1101/cshperspect.a007641 23125199
   PubMed Web of Science ®Google Scholar
• Turner R , Stratton I , Horton V , et al. UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet . 1997;350(9087):1288–1293. doi:10.1016/S0140-6736(97)03062-6 9357409
   PubMed Web of Science ®Google Scholar
• Cizza G , Brown RJ , Rothe KI . Rising incidence and challenges of childhood diabetes. A mini review. J Endocrinol Invest . 2012;35(5):541–546. doi:10.3275/8411 22572768
   PubMed Web of Science ®Google Scholar
• Kaufman FR . Type 2 Diabetes in Children and Young Adults: a “New Epidemic”. Clin Diabetes . 2002;20(4):217–218. doi:10.2337/diaclin.20.4.217
   Google Scholar
• D’Adamo E , Caprio S . Type 2 diabetes in youth: epidemiology and pathophysiology. Diabetes Care . 2011;34(Suppl 2):S161–S165. doi:10.2337/dc11-s212 21525449
   PubMed Web of Science ®Google Scholar
• Liao C , Zhang D , Mungo C , Tompkins DA , Zeidan AM . Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecol Oncol . 2014;135(1):163–171. doi:10.1016/j.ygyno.2014.07.095 25072931
   PubMed Web of Science ®Google Scholar
• Saeedi P , Petersohn I , Salpea P , et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract . 2019;2:157.
   Google Scholar
• Ginter E , Type VS . 2 diabetes mellitus, pandemic in 21st century. Adv Exp Med Biol . 2012;771:42–50.23393670
   PubMed Web of Science ®Google Scholar
• Mi H . Diabetes in America . New York: U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES* Public Health Service* National Institutes of Health; 1985.
   Google Scholar
• Kaveeshwar SA , Cornwall J . The current state of diabetes mellitus in India. Australas Med J . 2014;7(1):45–48. doi:10.4066/AMJ.2014.1979 24567766
   PubMedGoogle Scholar
• Sosale A , Prasanna Kumar KM , Sadikot SM , et al. Chronic complications in newly diagnosed patients with Type 2 diabetes mellitus in India. Indian J Endocrinol Metab . 2014;18(3):355–360. doi:10.4103/2230-8210.131184 24944931
   PubMedGoogle Scholar
• Burke JP , Williams K , Gaskill SP , Hazuda HP , Haffner SM , Stern MP . Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the san antonio heart study. Arch Intern Med . 1999;159(13):1450–1456. doi:10.1001/archinte.159.13.1450 10399896
   PubMedGoogle Scholar
• Bos M , Agyemang C . Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC Public Health . 2013;13:387. doi:10.1186/1471-2458-13-387 23617762
   PubMed Web of Science ®Google Scholar
• Ardisson Korat AV , Willett WC , Hu FB . Diet, lifestyle, and genetic risk factors for type 2 diabetes: a review from the Nurses’ Health Study, Nurses’ Health Study 2, and Health Professionals’ Follow-up Study. Curr Nutr Rep . 2014;3(4):345–354. doi:10.1007/s13668-014-0103-5 25599007
   PubMedGoogle Scholar
• Nguyen NT , Nguyen X-MT , Lane J , Wang P . Relationship Between Obesity and Diabetes in a US Adult Population: findings from the National Health and Nutrition Examination Survey, 1999–2006. Obes Surg . 2011;21(3):351–355. doi:10.1007/s11695-010-0335-4 21128002
   PubMed Web of Science ®Google Scholar
• George AM , Jacob AG , Fogelfeld L . Lean diabetes mellitus: an emerging entity in the era of obesity. World J Diabetes . 2015;6(4):613–620. doi:10.4239/wjd.v6.i4.613 25987958
   PubMedGoogle Scholar
• Ma RCW , Chan JCN . Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci . 2013;1281(1):64–91. doi:10.1111/nyas.12098 23551121
   PubMed Web of Science ®Google Scholar
• Gastaldelli A . Abdominal fat: does it predict the development of type 2 diabetes? Am J Clin Nutr . 2008;87(5):1118–1119. doi:10.1093/ajcn/87.5.1118 18469227
   PubMed Web of Science ®Google Scholar
• Noble JA , Erlich HA . Genetics of Type 1 Diabetes. Cold Spring Harb Perspect Med . 2012;2(1):a007732. doi:10.1101/cshperspect.a007732 22315720
   PubMed Web of Science ®Google Scholar
• Ahlqvist E , Ahluwalia TS , Groop L . Genetics of Type 2 Diabetes. Clin Chem . 2011;57(2):241–254. doi:10.1373/clinchem.2010.157016 21119033
   PubMed Web of Science ®Google Scholar
• Hyttinen V , Kaprio J , Kinnunen L , Koskenvuo M , Tuomilehto J . Genetic Liability of Type 1 Diabetes and the Onset Age Among 22,650 Young Finnish Twin Pairs. Nationwide Follow Up Study . 2003;52(4):1052–1055.
   Google Scholar
• Poulsen P , Grunnet LG , Pilgaard K , et al. Increased Risk of Type 2 Diabetes in Elderly Twins. Diabetes . 2009;58(6):1350–1355. doi:10.2337/db08-1714 19336677
   PubMed Web of Science ®Google Scholar
• Mozaffarian D , Kamineni A , Carnethon M , Djoussé L , Mukamal KJ , Siscovick D . Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med . 2009;169(8):798–807. doi:10.1001/archinternmed.2009.21 19398692
   PubMedGoogle Scholar
• Kelly SJIM . Stress and type 2 diabetes: a review of how stress contributes to the development of type 2 diabetes. Annu Rev Public Health . 2015;18:441–462. doi:10.1146/annurev-publhealth-031914-122921
   Web of Science ®Google Scholar
• Kautzky-Willer A , Harreiter J , Pacini G . Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus. Endocr Rev . 2016;37(3):278–316.27159875
   PubMed Web of Science ®Google Scholar
• Sattar N . Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab . 2013;27(4):501–507. doi:10.1016/j.beem.2013.05.006 24054927
   PubMed Web of Science ®Google Scholar
• Doró P , Benkő R , Matuz M , Soós G . Seasonality in the Incidence of Type 2 Diabetes. Diabetes Care . 2006;29(1):173. doi:10.2337/diacare.29.01.06.dc05-1839 16373925
   PubMed Web of Science ®Google Scholar
• Si J , Yu C , Guo Y , et al. Season of birth and the risk of type 2 diabetes in adulthood: a prospective cohort study of 0.5 million Chinese adults. Diabetologia . 2017;60(5):836–842. doi:10.1007/s00125-016-4200-4 28064359
   PubMed Web of Science ®Google Scholar
• Corkey BE . Diabetes: have We Got It All Wrong?: insulin hypersecretion and food additives: cause of obesity and diabetes? Diabetes Care . 2012;35(12):2432–2437. doi:10.2337/dc12-0825 23173132
   PubMed Web of Science ®Google Scholar
• Alonso-Magdalena P , Quesada INA . Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol . 2011;7:346–353. doi:10.1038/nrendo.2011.56 21467970
   PubMed Web of Science ®Google Scholar
• Sun Y , Pei W , Wu Y , Yang Y . An Association of Herpes Simplex Virus Type 1 Infection With Type 2 Diabetes. Diabetes Care . 2005;28(2):435. doi:10.2337/diacare.28.2.435 15677810
   PubMed Web of Science ®Google Scholar
• Wang C-S , Wang S-T , Yao W-J , Chang -T-T , Chou P . Hepatitis C Virus Infection and the Development of Type 2 Diabetes in a Community-based Longitudinal Study. Am J Epidemiol . 2007;166(2):196–203. doi:10.1093/aje/kwm061 17496314
   PubMed Web of Science ®Google Scholar
• Bose SK , Ray R . Hepatitis C virus infection and insulin resistance. World J Diabetes . 2014;5(1):52–58. doi:10.4239/wjd.v5.i1.52 24567801
   PubMedGoogle Scholar
• Torres DM , Harrison SA . Hepatitis C virus and insulin resistance/diabetes mellitus. Gastroenterol Hepatol (N Y) . 2008;4(8):568–570.21960938
   PubMedGoogle Scholar
• Bansal N . Prediabetes diagnosis and treatment: a review. World J Diabetes . 2015;6(2):296–303. doi:10.4239/wjd.v6.i2.296 25789110
   PubMed Web of Science ®Google Scholar
• Tabák AG , Herder C , Rathmann W , Brunner EJ , Kivimäki M . Prediabetes: a high-risk state for developing diabetes. Lancet . 2012;379(9833):2279–2290. doi:10.1016/S0140-6736(12)60283-9 22683128
   PubMed Web of Science ®Google Scholar
• Tuso P . Prediabetes and lifestyle modification: time to prevent a preventable disease. Permanente J Summer . 2014;18(3):88–93. doi:10.7812/TPP/14-002
   PubMedGoogle Scholar
• Davidson MB , Schriger DL , Peters AL , Lorber B . Revisiting the oral glucose tolerance test criterion for the diagnosis of diabetes. J Gen Intern Med . 2000;15(8):551–555. doi:10.1046/j.1525-1497.2000.08024.x 10940146
   PubMed Web of Science ®Google Scholar
• Affourtit C . Mitochondrial involvement in skeletal muscle insulin resistance: a case of imbalanced bioenergetics. Biochimica Et Biophysica Acta . 2016;1857(10):1678–1693.27473535
   PubMed Web of Science ®Google Scholar
• Muoio DM , Newgard CB . Molecular and metabolic mechanisms of insulin resistance and [beta]-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol . 2008;9(3):193–205. doi:10.1038/nrm2327 18200017
   PubMed Web of Science ®Google Scholar
• Linnemann AK , Baan M , Davis DB . Pancreatic β-Cell Proliferation in Obesity. Adv Nutrition . 2014;5(3):278–288. doi:10.3945/an.113.005488
   Web of Science ®Google Scholar
• Mehran Arya E , Templeman Nicole M , Brigidi GS , et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab . 2012;16(6):723–737. doi:10.1016/j.cmet.2012.10.019 23217255
   PubMed Web of Science ®Google Scholar
• Boland BB , Rhodes CJ , Grimsby JS . The dynamic plasticity of insulin production in β-cells. Mol Metab . 2017;6(9):958–973.28951821
   PubMed Web of Science ®Google Scholar
• Cerf ME . Beta Cell Dysfunction and Insulin Resistance. Front Endocrinol (Lausanne) . 2013;4:37. doi:10.3389/fendo.2013.00037 23542897
   PubMedGoogle Scholar
• Achenbach P , Hummel M , Thümer L , Boerschmann H , Höfelmann D , Ziegler AG . Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children. Diabetologia . 2013;56(7):1615–1622. doi:10.1007/s00125-013-2896-y 23539116
   PubMed Web of Science ®Google Scholar
• Breuer TGK , Menge BA , Banasch M , et al. Proinsulin levels in patients with pancreatic diabetes are associated with functional changes in insulin secretion rather than pancreatic β-cell area. Eur J Endocrinol . 2010;163(4):551–558. doi:10.1530/EJE-10-0330 20679359
   PubMed Web of Science ®Google Scholar
• Pfützner A , Hermanns I , Ramljak S , et al. Elevated Intact proinsulin levels during an oral glucose challenge indicate progressive cell dysfunction and may be predictive for development of type 2 diabetes. J Diabetes Sci Technol . 2015;9(6):1307–1312. doi:10.1177/1932296815607862 26420624
   PubMedGoogle Scholar
• Vangipurapu J , Stančáková A , Kuulasmaa T , Kuusisto J , Laakso M . Both Fasting and Glucose-Stimulated Proinsulin Levels Predict Hyperglycemia and Incident Type 2 Diabetes: a Population-Based Study of 9,396 Finnish Men. PLoS One . 2015;10(4):e0124028. doi:10.1371/journal.pone.0124028 25853252
   PubMed Web of Science ®Google Scholar
• Cernea S , Dobreanu M . Diabetes and beta cell function: from mechanisms to evaluation and clinical implications. Biochem Med (Zagreb) . 2013;23(3):266–280. doi:10.11613/BM.2013.033 24266296
   PubMed Web of Science ®Google Scholar
• Wilcox G . Insulin and Insulin Resistance. Clin Biochemist Rev . 2005;26(2):19–39.
   PubMedGoogle Scholar
• Perilli G , Saraceni C , Daniels MN , Ahmad A . Diabetic ketoacidosis: a review and update. Curr Emerg Hosp Med Rep . 2013;1(1):10–17. doi:10.1007/s40138-012-0001-3
   Google Scholar
• Woerle HJ , Carneiro L , Derani A , Göke B , Schirra J . The role of endogenous incretin secretion as amplifier of glucose-stimulated insulin secretion in healthy subjects and patients with type 2 diabetes. Diabetes . 2012;61(9):2349–2358. doi:10.2337/db11-1701 22721966
   PubMed Web of Science ®Google Scholar
• Atkinson MA , Eisenbarth GS , Michels AW . Type 1 diabetes. Lancet . 2014;383(9911):69–82. doi:10.1016/S0140-6736(13)60591-7 23890997
   PubMed Web of Science ®Google Scholar
• White H , Venkatesh B . Clinical review: ketones and brain injury. Critical Care . 2011;15(2):219. doi:10.1186/cc10020 21489321
   PubMed Web of Science ®Google Scholar
• Gosmanov AR , Gosmanova EO , Dillard-Cannon E . Management of adult diabetic ketoacidosis. Diabetes Metab Syndrome Obesity . 2014;7:255–264. doi:10.2147/DMSO.S50516
   PubMedGoogle Scholar
• Olson AL . Regulation of GLUT4 and Insulin-Dependent Glucose Flux. ISRN Molecular Biol . 2012;2012:12. doi:10.5402/2012/856987
   Google Scholar
• Hardy OT , Czech MP , Corvera S . What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes . 2012;19(2):81–87. doi:10.1097/MED.0b013e3283514e13 22327367
   PubMed Web of Science ®Google Scholar
• Goodpaster BH , He J , Watkins S , Kelley DE . Skeletal Muscle Lipid Content and Insulin Resistance: evidence for a Paradox in Endurance-Trained Athletes. J Clin Endocrinol Metab . 2001;86(12):5755–5761. doi:10.1210/jcem.86.12.8075 11739435
   PubMed Web of Science ®Google Scholar
• van Loon LJC , Koopman R , Manders R , van der Weegen W , van Kranenburg GP , Keizer HA . Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol . 2004;287(3):E558–E565. doi:10.1152/ajpendo.00464.2003
   PubMed Web of Science ®Google Scholar
• Vaag A , Lund SS . Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention? Applied Physiol Nutrition Metab . 2007;32(5):912–920. doi:10.1139/H07-100 18059616
   PubMed Web of Science ®Google Scholar
• Chang SA , Kim HS , Yoon KH , et al. Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea. Metab Clin Exp . 2004;53(2):142–146. doi:10.1016/S0026-0495(03)00314-7 14767863
   PubMed Web of Science ®Google Scholar
• Khaodhiar L , Cummings S , Apovian CM . Treating diabetes and prediabetes by focusing on obesity management. Curr Diab Rep . 2009;9(5):348–354. doi:10.1007/s11892-009-0055-0 19793504
   PubMed Web of Science ®Google Scholar
• Madeira FB , Silva AA , Veloso HF , et al. Normal Weight Obesity Is Associated with Metabolic Syndrome and Insulin Resistance in Young Adults from a Middle-Income Country. PLoS One . 2013;8(3):e60673. doi:10.1371/journal.pone.0060673 23556000
   PubMed Web of Science ®Google Scholar
• Lim EL , Hollingsworth KG , Aribisala BS , Chen MJ , Mathers JC , Taylor R . Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia . 2011;54(10):2506–2514. doi:10.1007/s00125-011-2204-7 21656330
   PubMed Web of Science ®Google Scholar
• Taylor R . Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia . 2008;51(10):1781–1789. doi:10.1007/s00125-008-1116-7 18726585
   PubMed Web of Science ®Google Scholar
• DeLany JP , Dubé JJ , Standley RA , et al. Racial Differences In Peripheral Insulin Sensitivity and Mitochondrial Capacity in the Absence of Obesity. J Clin Endocrinol Metab . 2014;99(11):4307–4314. doi:10.1210/jc.2014-2512 25105736
   PubMed Web of Science ®Google Scholar
• Khoo CM , Leow MK-S , Sadananthan SA , et al. Body Fat Partitioning Does Not Explain the Interethnic Variation in Insulin Sensitivity Among Asian Ethnicity: the Singapore Adults Metabolism Study. Diabetes . 2014;63(3):1093–1102. doi:10.2337/db13-1483 24353181
   PubMed Web of Science ®Google Scholar
• Yoshino J , Almeda-Valdes P , Patterson BW , et al. Diurnal Variation in Insulin Sensitivity of Glucose Metabolism Is Associated With Diurnal Variations in Whole-Body and Cellular Fatty Acid Metabolism in Metabolically Normal Women. J Clin Endocrinol Metab . 2014;99(9):E1666–E1670. doi:10.1210/jc.2014-1579 24878055
   PubMed Web of Science ®Google Scholar
• Butler AE , Janson J , Bonner-Weir S , Ritzel R , Rizza RA , Butler PC . β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes. Diabetes . 2003;52(1):102–110. doi:10.2337/diabetes.52.1.102 12502499
   PubMed Web of Science ®Google Scholar
• Biarnés M , Montolio M , Nacher V , Raurell M , Soler J , Montanya E . β-Cell Death and Mass in Syngeneically Transplanted Islets Exposed to Short- and Long-Term Hyperglycemia. Diabetes . 2002;51(1):66–72. doi:10.2337/diabetes.51.1.66 11756324
   PubMed Web of Science ®Google Scholar
• Bretherton-Watt D , Ghatei MA , Bloom SR , et al. Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes. Diabetologia . 1989;32(12):881–883. doi:10.1007/BF00297454 2612759
   PubMed Web of Science ®Google Scholar
• Mulder H , Ahrén B , Sundler F . Islet amyloid polypeptide (amylin) and insulin are differentially expressed in chronic diabetes induced by streptozotocin in rats. Diabetologia . 1996;39(6):649–657. doi:10.1007/BF00418536 8781760
   PubMed Web of Science ®Google Scholar
• Gupta D , Leahy JL . Islet amyloid and type 2 diabetes: overproduction or inadequate clearance and detoxification? J Clin Invest . 2014;124(8):3292–3294. doi:10.1172/JCI77506 25036704
   PubMed Web of Science ®Google Scholar
• Alrefai HA , Latif KA , Hieronymus LB , Weakley CR , Moss RJ . Pramlintide: clinical Strategies for Success. Diabetes Spectrum . 2010;23(2):124–130. doi:10.2337/diaspect.23.2.124
   Google Scholar
• Howard CJ . Diabetes mellitus: relationships of nonhuman primates and other animal models to human forms of diabetes. Adv Vet Sci Comp Med . 1984;28:115–149.6395671
   PubMedGoogle Scholar
• Matveyenko AV , Butler PC . Islet Amyloid Polypeptide (IAPP) Transgenic Rodents as Models for Type 2 Diabetes. ILAR J . 2006;47(3):225–233. doi:10.1093/ilar.47.3.225 16804197
   PubMed Web of Science ®Google Scholar
• Shigihara N , Fukunaka A , Hara A , et al. Human IAPP–induced pancreatic β cell toxicity and its regulation by autophagy. J Clin Invest . 2014;124(8):3634–3644. doi:10.1172/JCI69866 25036706
   PubMed Web of Science ®Google Scholar
• Cnop M , Welsh N , Jonas J-C , Jörns A , Lenzen S , Eizirik DL . Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes. Many Differences Few Similarities . 2005;54(suppl2):S97–S107.
   Google Scholar
• Costanzo P , Cleland JF , Pellicori P , et al. The obesity paradox in type 2 diabetes mellitus: relationship of body mass index to prognosis: a cohort study. Ann Intern Med . 2015;162(9):610–618. doi:10.7326/M14-1551 25938991
   PubMed Web of Science ®Google Scholar
• Hainer V , Aldhoon-Hainerová I . Obesity Paradox Does Exist. Diabetes Care . 2013;36(Supplement 2):S276–S281. doi:10.2337/dcS13-2023 23882059
   PubMed Web of Science ®Google Scholar
• Doehner W , Erdmann E , Cairns R , et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol . 2012;162(1):20–26. doi:10.1016/j.ijcard.2011.09.039 22037349
   PubMed Web of Science ®Google Scholar
• Sohn M-W , Budiman-Mak E , Oh EH , et al. Obesity Paradox in Amputation Risk Among Nonelderly Diabetic Men. Obesity . 2012;20(2):460–462. doi:10.1038/oby.2011.301 21996669
   PubMed Web of Science ®Google Scholar
• Coleman NJ , Miernik J , Philipson L , Fogelfeld L . Lean versus obese diabetes mellitus patients in the United States minority population. J Diabetes Complications . 2013;28(4):500–505. doi:10.1016/j.jdiacomp.2013.11.010 24581791
   PubMed Web of Science ®Google Scholar
• Kim JY , Song EH , Lee HJ , et al. Chronic Ethanol Consumption-induced Pancreatic β-Cell Dysfunction and Apoptosis through Glucokinase Nitration and Its Down-regulation. J Biol Chem . 2010;285(48):37251–37262. doi:10.1074/jbc.M110.142315 20855893
   PubMed Web of Science ®Google Scholar
• Gerich JE . Insulin Resistance Is Not Necessarily an Essential Component of Type 2 Diabetes1. J Clin Endocrinol Metab . 2000;85(6):2113–2115.10852436
   PubMed Web of Science ®Google Scholar
• Brereton MF , Vergari E , Zhang Q , Clark A . Alpha-, Delta- and PP-cells: are They the Architectural Cornerstones of Islet Structure and Co-ordination? J Histochem Cytochemistry . 2015;63(8):575–591. doi:10.1369/0022155415583535
   PubMed Web of Science ®Google Scholar
• Moon JS , Won KC . Pancreatic α-Cell Dysfunction in Type 2 Diabetes: old Kids on the Block. Diabetes Metab J . 2015;39(1):1–9. doi:10.4093/dmj.2015.39.1.1 25729706
   PubMed Web of Science ®Google Scholar
• Sherwin RS , Fisher M , Hendler R , Felig P . Hyperglucagonemia and Blood Glucose Regulation in Normal, Obese and Diabetic Subjects. N Eng J Med . 1976;294(9):455–461. doi:10.1056/NEJM197602262940901
   Web of Science ®Google Scholar
• Ivan Quesada ET , Ripoll C , Nadal Á . Physiology of the pancreatic α-cell and glucagon secretion: role in glucose homeostasis and diabetes. J Endocrinol . 2008;2:68–96.
   Google Scholar
• Dinneen S , Alzaid A , Turk D , Rizza R . Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Diabetologia . 1995;38(3):337–343. doi:10.1007/BF00400639 7758881
   PubMed Web of Science ®Google Scholar
• Reaven GM , Chen YDI , Golay A , Swislocki ALM , Jaspan JB . Documentation of Hyperglucagonemia Throughout the Day in Nonobese and Obese Patients with Noninsulin-Dependent Diabetes Mellitus*. J Clin Endocrinol Metab . 1987;64(1):106–110. doi:10.1210/jcem-64-1-106 3536980
   PubMed Web of Science ®Google Scholar
• Shah P , Vella A , Basu A , Basu R , Schwenk WF , Rizza RA . Lack of Suppression of Glucagon Contributes to Postprandial Hyperglycemia in Subjects with Type 2 Diabetes Mellitus1. J Clin Endocrinol Metab . 2000;85(11):4053–4059.11095432
   PubMed Web of Science ®Google Scholar
• Baron AD , Schaeffer L , Shragg P , Kolterman OG . Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics. Diabetes . 1987;36(3):274–283. doi:10.2337/diab.36.3.274 2879757
   PubMed Web of Science ®Google Scholar
• Kawamori D , Kurpad AJ , Hu J , et al. Insulin Signaling in α-cells Modulates Glucagon Secretion in vivo. Cell Metab . 2009;9(4):350–361. doi:10.1016/j.cmet.2009.02.007 19356716
   PubMed Web of Science ®Google Scholar
• Elder DA , Prigeon RL , Wadwa RP , Dolan LM , D’Alessio DA . β-Cell Function, Insulin Sensitivity, and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults. J Clin Endocrinol Metab . 2006;91(1):185–191. doi:10.1210/jc.2005-0853 16263830
   PubMed Web of Science ®Google Scholar
• Kilimnik G , Zhao B , Jo J , et al. Altered Islet Composition and Disproportionate Loss of Large Islets in Patients with Type 2 Diabetes. PLoS One . 2011;6(11):e27445. doi:10.1371/journal.pone.0027445 22102895
   PubMed Web of Science ®Google Scholar
• Brereton MF , Iberl M , Shimomura K , et al. Reversible changes in pancreatic islet structure and function produced by elevated blood glucose. Nat Commun . 2014;5:4639. doi:10.1038/ncomms5639 25145789
   PubMed Web of Science ®Google Scholar
• Clark A , Wells CA , Buley ID , et al. Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res . 1988;9:151–159.3073901
   PubMedGoogle Scholar
• Rahier J , Goebbels RM , Henquin JC . Cellular composition of the human diabetic pancreas. Diabetologia . 1983;24(5):366–371. doi:10.1007/BF00251826 6347784
   PubMed Web of Science ®Google Scholar
• Guardado Mendoza R , Perego C , Finzi G , et al. Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas). Diabetologia . 2015;58(8):1814–1826. doi:10.1007/s00125-015-3625-5 26049399
   PubMed Web of Science ®Google Scholar
• Talchai C , Xuan S , Lin HV , Sussel L , Accili D . Pancreatic β-Cell Dedifferentiation As Mechanism Of Diabetic β-Cell Failure. Cell . 2012;150(6):1223–1234. doi:10.1016/j.cell.2012.07.029 22980982
   PubMed Web of Science ®Google Scholar
• Ahrén B . Incretin dysfunction in type 2 diabetes: clinical impact and future perspectives. Diabetes Metab . 2013;39:195–201. doi:10.1016/j.diabet.2013.03.001 23643349
   PubMed Web of Science ®Google Scholar
• Meier JJ , Nauck MA . Is the Diminished Incretin Effect in Type 2 Diabetes Just an Epi-Phenomenon of Impaired β-Cell Function? Diabetes . 2010;59(5):1117–1125. doi:10.2337/db09-1899 20427697
   PubMed Web of Science ®Google Scholar
• Pratley RE . GIP: an Inconsequential Incretin or Not? Diabetes Care . 2010;33(7):1691–1692. doi:10.2337/dc10-0704 20587731
   PubMed Web of Science ®Google Scholar
• Nauck MA , Heimesaat MM , Orskov C , Holst JJ , Ebert R , Creutzfeldt W . Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest . 1993;91(1):301–307. doi:10.1172/JCI116186 8423228
   PubMed Web of Science ®Google Scholar
• Højberg PV , Vilsbøll T , Rabøl R , et al. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. Diabetologia . 2009;52(2):199. doi:10.1007/s00125-008-1195-5 19037628
   PubMed Web of Science ®Google Scholar
• Højberg PV , Vilsbøll T , Zander M , et al. Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes. Diabetic Med . 2008;25(11):1268–1275. doi:10.1111/j.1464-5491.2008.02579.x 19046215
   PubMed Web of Science ®Google Scholar
• Thorens B . Neural regulation of pancreatic islet cell mass and function. Diabetes Obes Metab . 2014;16(S1):87–95. doi:10.1111/dom.12346 25200301
   PubMed Web of Science ®Google Scholar
• Thorens B . Brain glucose sensing and neural regulation of insulin and glucagon secretion. Diabetes Obes Metab . 2011;13:82–88. doi:10.1111/j.1463-1326.2011.01453.x 21824260
   PubMed Web of Science ®Google Scholar
• Kiba T . Relationships between the autonomic nervous system and the pancreas including regulation of regeneration and apoptosis: recent developments. Pancreas . 2004;29:51–58. doi:10.1097/00006676-200408000-00019
   PubMed Web of Science ®Google Scholar
• Tarussio D , Metref S , Seyer P , et al. Nervous glucose sensing regulates postnatal β cell proliferation and glucose homeostasis. J Clin Invest . 2014;124(1):413–424. doi:10.1172/JCI69154 24334455
   PubMed Web of Science ®Google Scholar
• Poitout V , Amyot J , Semache M , Zarrouki B , Hagman D , Fontés G . Glucolipotoxicity of the Pancreatic Beta Cell. Biochim Biophys Acta . 2010;1801(3):289–298. doi:10.1016/j.bbalip.2009.08.006 19715772
   PubMed Web of Science ®Google Scholar
• Kim J-W , Yoon K-H . Glucolipotoxicity in Pancreatic β-Cells. Diabetes Metab J . 2011;35(5):444–450. doi:10.4093/dmj.2011.35.5.444 22111034
   PubMedGoogle Scholar
• Prentki M , Nolan CJ . Islet β cell failure in type 2 diabetes. J Clin Invest . 2006;116(7):1802–1812. doi:10.1172/JCI29103 16823478
   PubMed Web of Science ®Google Scholar
• Mason TM , Goh T , Tchipashvili V , et al. Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes . 1999;48(3):524–530. doi:10.2337/diabetes.48.3.524 10078552
   PubMed Web of Science ®Google Scholar
• Kashyap S , Belfort R , Gastaldelli A , et al. A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes. Diabetes . 2003;52(10):2461–2474. doi:10.2337/diabetes.52.10.2461 14514628
   PubMed Web of Science ®Google Scholar
• Barlow J , Affourtit C . Novel insights into pancreatic β-cell glucolipotoxicity from real-time functional analysis of mitochondrial energy metabolism in INS-1E insulinoma cells. Biochemical J . 2013;456(3):417–426. doi:10.1042/BJ20131002
   Web of Science ®Google Scholar
• Barlow J , Jensen Verena H , Jastroch M , Affourtit C . Palmitate-induced impairment of glucose-stimulated insulin secretion precedes mitochondrial dysfunction in mouse pancreatic islets. Biochemical J . 2016;473(4):487–496. doi:10.1042/BJ20151080
   PubMed Web of Science ®Google Scholar
• Hogan AE , Tobin AM , Ahern T , et al. Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis. Diabetologia . 2011;54(11):2745–2754. doi:10.1007/s00125-011-2232-3 21744074
   PubMed Web of Science ®Google Scholar
• Wang Z , Thurmond DC . Mechanisms of biphasic insulin-granule exocytosis – roles of the cytoskeleton, small GTPases and SNARE proteins. J Cell Sci . 2009;122(7):893. doi:10.1242/jcs.034355 19295123
   PubMed Web of Science ®Google Scholar
• Athauda D , Maclagan K , Skene SS , et al. Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial. Lancet . 2017;390(10103):1664–1675. doi:10.1016/S0140-6736(17)31585-4 28781108
   PubMed Web of Science ®Google Scholar
• Lynn FC , Pamir N , Ng EHC , McIntosh CHS , Kieffer TJ , Pederson RA . Defective Glucose-Dependent Insulinotropic Polypeptide Receptor Expression in Diabetic Fatty Zucker Rats. Diabetes . 2001;50(5):1004–1011. doi:10.2337/diabetes.50.5.1004 11334402
   PubMed Web of Science ®Google Scholar
• Affourtit C , Brand martin D . Uncoupling protein-2 contributes significantly to high mitochondrial proton leak in INS-1E insulinoma cells and attenuates glucose-stimulated insulin secretion. Biochemical J . 2008;409(1):199–204. doi:10.1042/BJ20070954
   Web of Science ®Google Scholar
• Affourtit C , Brand MD . On the role of uncoupling protein-2 in pancreatic beta cells. Biochimica et Biophysica Acta . 2008;1777(7–8):973–979. doi:10.1016/j.bbabio.2008.03.022 18433713
   PubMed Web of Science ®Google Scholar
• Affourtit C , Jastroch M , Brand MD . Uncoupling protein-2 attenuates glucose-stimulated insulin secretion in INS-1E insulinoma cells by lowering mitochondrial reactive oxygen species. Free Radic Biol Med . 2011;50(5):609–616. doi:10.1016/j.freeradbiomed.2010.12.020 21172424
   PubMed Web of Science ®Google Scholar
• Chan CB , De Leo D , Joseph JW , et al. Increased uncoupling protein-2 levels in β-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action. Diabetes . 2001;50(6):1302–1310. doi:10.2337/diabetes.50.6.1302 11375330
   PubMed Web of Science ®Google Scholar
• Chan CB , MacDonald PE , Saleh MC , Johns DC , Marbàn E , Wheeler MB . Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. Diabetes . 1999;48(7):1482–1486. doi:10.2337/diabetes.48.7.1482 10389858
   PubMed Web of Science ®Google Scholar
• Pi J , Collins S . Reactive oxygen species and uncoupling protein 2 in pancreatic β‐cell function. Diabetes Obes Metab . 2010;12(s2):141–148. doi:10.1111/j.1463-1326.2010.01269.x 21029311
   PubMed Web of Science ®Google Scholar
• Robson-Doucette CA , Sultan S , Allister EM , et al. β-Cell Uncoupling Protein 2 Regulates Reactive Oxygen Species Production, Which Influences Both Insulin and Glucagon Secretion. Diabetes . 2011;60(11):2710–2719. doi:10.2337/db11-0132 21984579
   PubMed Web of Science ®Google Scholar
• Schrauwen P , Hesselink M . UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol . 2002;205(15):2275. doi:10.1242/jeb.205.15.2275 12110661
   PubMed Web of Science ®Google Scholar
• Bensellam M , Laybutt DR , Jonas J-C . The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions. Mol Cell Endocrinol . 2012;364(1–2):1–27.22885162
   PubMed Web of Science ®Google Scholar
• Hirschberg Jensen V , Affourtit C . Mitochondrial uncoupling protein-2 is not involved in palmitate-induced impairment of glucose-stimulated insulin secretion in INS-1E insulinoma cells and is not needed for the amplification of insulin release. Biochemistry Biophysics Rep . 2015;1:8–15. doi:10.1016/j.bbrep.2015.03.008
   Google Scholar
• Vozza A , Parisi G , De Leonardis F , et al. UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci U S A . 2014;111(3):960–965. doi:10.1073/pnas.1317400111 24395786
   PubMed Web of Science ®Google Scholar
• Mailloux RJ , Fu A , Robson-Doucette C , et al. Glutathionylation State of Uncoupling Protein-2 and the Control of Glucose-stimulated Insulin Secretion. J Biol Chem . 2012;287(47):39673–39685. doi:10.1074/jbc.M112.393538 23035124
   PubMed Web of Science ®Google Scholar
• Mailloux RJ , Seifert EL , Bouillaud F , Aguer C , Collins S , Harper M-E . Glutathionylation Acts as a Control Switch for Uncoupling Proteins UCP2 and UCP3. J Biol Chem . 2011;286(24):21865–21875. doi:10.1074/jbc.M111.240242 21515686
   PubMed Web of Science ®Google Scholar
• Basu R , Barosa C , Jones J , et al. Pathogenesis of Prediabetes: role of the Liver in Isolated Fasting Hyperglycemia and Combined Fasting and Postprandial Hyperglycemia. J Clin Endocrinol Metab . 2013;98(3):E409–E417. doi:10.1210/jc.2012-3056 23345093
   PubMed Web of Science ®Google Scholar
• Phielix E , Mensink M . Type 2 Diabetes Mellitus and Skeletal Muscle Metabolic Function. Physiol Behav . 2008;94(2):252–258. doi:10.1016/j.physbeh.2008.01.020 18342897
   PubMed Web of Science ®Google Scholar
• De Macedo G , Maria C , Nunes S , Barreto T . Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr . 2016;8(1):63. doi:10.1186/s13098-016-0176-y 27583022
   PubMed Web of Science ®Google Scholar
• Krishnan B , Babu S , Walker J , Walker AB , Pappachan JM . Gastrointestinal complications of diabetes mellitus. World J Diabetes . 2013;4(3):51–63. doi:10.4239/wjd.v4.i3.51 23772273
   PubMedGoogle Scholar
• Sharaf El Din A , Abdulazim DO . Diabetic nephropathy: time to withhold development and progression - A review. J Adv Res . 2017;8(4):363–373. doi:10.1016/j.jare.2017.04.004 28540086
   PubMed Web of Science ®Google Scholar
• Sanad E , ElFangary M , Sorour N , ElNemisy N . Skin manifestations in Egyptian diabetic patients: a case series study. Egypt J Dermatol Venerology . 2013;33(2):56–62. doi:10.4103/1110-6530.123941
   Google Scholar
• DeFronzo RA , Tripathy D . Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes. Diabetes Care . 2009;32(Suppl 2):S157–S163. doi:10.2337/dc09-S302 19875544
   PubMed Web of Science ®Google Scholar
• Blaak EE , van Aggel-leijssen DP , Wagenmakers AJ , Saris WH , van Baak MA . Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes . 2000;49(12):2102. doi:10.2337/diabetes.49.12.2102 11118013
   PubMed Web of Science ®Google Scholar
• Mensink M , Blaak EE , van Baak MA , Wagenmakers AJM , Saris WHM . Plasma Free Fatty Acid Uptake and Oxidation Are Already Diminished in Subjects at High Risk for Developing Type 2 Diabetes. Diabetes . 2001;50(11):2548. doi:10.2337/diabetes.50.11.2548 11679433
   PubMed Web of Science ®Google Scholar
• Holloszy JO . “Deficiency” of Mitochondria in Muscle Does Not Cause Insulin Resistance. Diabetes . 2013;62(4):1036. doi:10.2337/db12-1107 23520283
   PubMed Web of Science ®Google Scholar
• van de Weijer T , Sparks LM , Phielix E , et al. Relationships between Mitochondrial Function and Metabolic Flexibility in Type 2 Diabetes Mellitus. PLoS One . 2013;8(2):e51648. doi:10.1371/journal.pone.0051648 23418416
   PubMed Web of Science ®Google Scholar
• Galgani JE , Heilbronn LK , Azuma K , et al. Metabolic Flexibility in Response to Glucose Is Not Impaired in People With Type 2 Diabetes After Controlling for Glucose Disposal Rate. Diabetes . 2008;57(4):841–845. doi:10.2337/db08-0043 18285553
   PubMed Web of Science ®Google Scholar
• Goodpaster BH , Katsiaras A , Kelley DE . Enhanced Fat Oxidation Through Physical Activity Is Associated With Improvements in Insulin Sensitivity in Obesity. Diabetes . 2003;52(9):2191. doi:10.2337/diabetes.52.9.2191 12941756
   PubMed Web of Science ®Google Scholar
• Færch K , Vaag A . Metabolic inflexibility is a common feature of impaired fasting glycaemia and impaired glucose tolerance. Acta Diabetol . 2011;48(4):349–353. doi:10.1007/s00592-010-0245-x 21207234
   PubMed Web of Science ®Google Scholar
• Park SW , Goodpaster BH , Lee JS , et al. Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes. Diabetes Care . 2009;32(11):1993–1997. doi:10.2337/dc09-0264 19549734
   PubMed Web of Science ®Google Scholar
• Perry BD , Caldow MK , Brennan-Speranza TC , et al. Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise. Exerc Immunol Rev . 2016;22:94–109.26859514
   PubMed Web of Science ®Google Scholar
• Ciaraldi TP , Ryan AJ , Mudaliar SR , Henry RR . Altered Myokine Secretion Is an Intrinsic Property of Skeletal Muscle in Type 2 Diabetes. PLoS One . 2016;11(7):e0158209. doi:10.1371/journal.pone.0158209 27453994
   PubMed Web of Science ®Google Scholar
• Bouzakri K , Plomgaard P , Berney T , Donath MY , Pedersen BK , Halban PA . Bimodal Effect on Pancreatic β-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle. Diabetes . 2011;60(4):1111–1121. doi:10.2337/db10-1178 21378173
   PubMed Web of Science ®Google Scholar
• Hancock CR , Han D-H , Chen M , et al. High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc National Acad Sci . 2008;105(22):7815–7820. doi:10.1073/pnas.0802057105
   PubMed Web of Science ®Google Scholar
• Turner N , Bruce CR , Beale SM , et al. Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle. Diabetes . 2007;56(8):2085. doi:10.2337/db07-0093 17519422
   PubMed Web of Science ®Google Scholar
• Sreekumar R , Unnikrishnan J , Fu A , et al. Impact of high-fat diet and antioxidant supplement on mitochondrial functions and gene transcripts in rat muscle. Am J Physiol Endocrinol Metabo . 2002;282(5):E1055–E1061. doi:10.1152/ajpendo.00554.2001
   Web of Science ®Google Scholar
• Beck-Nielsen H , Hother-Nielsen O , Staehr P . Is hepatic glucose production increased in type 2 diabetes mellitus? Curr Diab Rep . 2002;2(3):231–236. doi:10.1007/s11892-002-0088-0 12643178
   PubMedGoogle Scholar
• Bhatt HB , Smith RJ . Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr . 2015;4(2):101–108. doi:10.3978/j.issn.2304-3881.2015.01.03 26005676
   PubMed Web of Science ®Google Scholar
• Mazzotti A , Caletti MT , Marchignoli F , Forlani G , Marchesini G . Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease? Digestive Liver Dis . 2017;49(3):235–240. doi:10.1016/j.dld.2016.12.028
   Web of Science ®Google Scholar
• Targher G , Day CP , Bonora E . Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease. N Eng J Med . 2010;363(14):1341–1350. doi:10.1056/NEJMra0912063
   PubMed Web of Science ®Google Scholar
• Rijkelijkhuizen JM , Doesburg T , Girman CJ , et al. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response. Metab Clin Exp . 2009;58(2):196–203. doi:10.1016/j.metabol.2008.09.013 19154952
   PubMed Web of Science ®Google Scholar
• Gurgul-Convey E , Mehmeti I , Lortz S , Lenzen S . Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria. J Mol Med . 2011;89(8):785–798. doi:10.1007/s00109-011-0747-1 21487676
   PubMed Web of Science ®Google Scholar
• Makki K , Froguel P , Wolowczuk I . Adipose Tissue in Obesity-Related Inflammation and Insulin Resistance: cells, Cytokines, and Chemokines. ISRN Inflammation . 2013;2013:139239. doi:10.1155/2013/139239 24455420
   PubMedGoogle Scholar
• Frayn KN . Adipose tissue and the insulin resistance syndrome. Proc Nutrition Soc . 2007;60(3):375–380. doi:10.1079/PNS200195
   Web of Science ®Google Scholar
• Blaak EE . Fatty acid metabolism in obesity and type 2 diabetes mellitus. Proc Nutrition Soc . 2007;62(3):753–760. doi:10.1079/PNS2003290
   Web of Science ®Google Scholar
• Moreno-Indias I , Cardona F , Tinahones FJ , Queipo-Ortuño MI . Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus. Front Microbiol . 2014;5:190. doi:10.3389/fmicb.2014.00190 24808896
   PubMed Web of Science ®Google Scholar
• Rubin MR , Patsch JM . Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions. Bone Res . 2016;4:16001. doi:10.1038/boneres.2016.1 27019762
   PubMed Web of Science ®Google Scholar
• Dobnig H , Piswanger-Sölkner JC , Roth M , et al. Type 2 Diabetes Mellitus in Nursing Home Patients: effects on Bone Turnover, Bone Mass, and Fracture Risk. J Clin Endocrinol Metab . 2006;91(9):3355–3363. doi:10.1210/jc.2006-0460 16735485
   PubMed Web of Science ®Google Scholar
• Yamamoto M , Yamaguchi T , Nawata K , Yamauchi M , Sugimoto T . Decreased PTH Levels Accompanied by Low Bone Formation Are Associated with Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes. J Clin Endocrinol Metab . 2012;97(4):1277–1284. doi:10.1210/jc.2011-2537 22337915
   PubMed Web of Science ®Google Scholar
• Wrighten SA , Piroli GG , Grillo CA , Reagan LP . A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochim Biophys Acta . 2009;1792(5):444–453. doi:10.1016/j.bbadis.2008.10.013 19022375
   PubMed Web of Science ®Google Scholar
• Ten Kulve JS , van Bloemendaal L , Balesar R , et al. Decreased Hypothalamic Glucagon-Like Peptide-1 Receptor Expression in Type 2 Diabetes Patients. J Clin Endocrinol Metab . 2016;101(5):2122–2129. doi:10.1210/jc.2015-3291 26672638
   PubMed Web of Science ®Google Scholar
• Pirart J . Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed. Diabetes Care . 1978;1:168–188. doi:10.2337/diacare.1.3.168
   Google Scholar
• Yagihashi S , Mizukami H , Sugimoto K . Mechanism of diabetic neuropathy: where are we now and where to go? J Diabetes Investig . 2011;2(1):18–32. doi:10.1111/j.2040-1124.2010.00070.x
   PubMed Web of Science ®Google Scholar
• Duby JJ , Campbell RK , Setter SM . Diabetic neuropathy: an intensive review. Am J Health Sys Pharmacy . 2004;61(2):160. doi:10.1093/ajhp/61.2.160
   Web of Science ®Google Scholar
• Tracy JA , Dyck PJB . The Spectrum of Diabetic Neuropathies. Phys Med Rehabil Clin N Am . 2008;19(1):1–26. doi:10.1016/j.pmr.2007.10.010 18194747
   PubMed Web of Science ®Google Scholar
• Nesto R , Fain R , Li Y , Shanahan W . Evaluation of lorcaserin on progression of prediabetes to type 2 diabetes and reversion to euglycemia. Postgrad Med . 2016;128(4):364–370. doi:10.1080/00325481.2016.1178590 27116910
   PubMed Web of Science ®Google Scholar
• Dokken BB . The Pathophysiology of Cardiovascular Disease and Diabetes: beyond Blood Pressure and Lipids. Diabetes Spectrum . 2008;21(3):160. doi:10.2337/diaspect.21.3.160
   Google Scholar
• Funk SD , Ory AW . Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: lessons from Type 1 Diabetes. Int J Vasc Med . 2012;2012. doi:10.1155/2012/569654
   Google Scholar
• Wu G , Meininger CJ . Nitric oxide and vascular insulin resistance. BioFactors . 2009;35(1):21–27. doi:10.1002/biof.3 19319842
   PubMed Web of Science ®Google Scholar
• Lastra G , Syed S , Kurukulasuriya LR , Manrique C , Sowers JR . Type 2 diabetes mellitus and hypertension: an update. Endocrinol Metab Clin North Am . 2014;43(1):103–122. doi:10.1016/j.ecl.2013.09.005 24582094
   PubMed Web of Science ®Google Scholar
• Tate M , Chong A , Robinson E , Green BD , Grieve DJ . Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes. Br J Pharmacol . 2015;172(3):721–736. doi:10.1111/bph.12943 25231355
   PubMed Web of Science ®Google Scholar
• Verrotti A , Prezioso G , Scattoni R , Chiarelli F . Autonomic Neuropathy in Diabetes Mellitus. Front Endocrinol (Lausanne) . 2014;5:205. doi:10.3389/fendo.2014.00205 25520703
   PubMed Web of Science ®Google Scholar
• Nourooz-Zadeh J , Rahimi A , Tajaddini-Sarmadi J , et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia . 1997;40(6):647–653. doi:10.1007/s001250050729 9222643
   PubMed Web of Science ®Google Scholar
• Kawaguchi M , Techigawara M , Ishihata T , et al. A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels . 1997;12(6):267–274. doi:10.1007/BF02766802 9860193
   PubMed Web of Science ®Google Scholar
• Cao Z , Cooper ME . Pathogenesis of diabetic nephropathy. J Diabetes Investig . 2011;2(4):243–247. doi:10.1111/j.2040-1124.2011.00131.x
   PubMed Web of Science ®Google Scholar
• Nitzan O , Elias M , Chazan B , Saliba W . Urinary tract infections in patients with type 2 diabetes mellitus: review of prevalence, diagnosis, and management. Diabetes Metab Syndrome Obesity . 2015;8:129–136. doi:10.2147/DMSO.S51792
   PubMed Web of Science ®Google Scholar
• Colberg SR , Sigal RJ , Fernhall B , et al. Exercise and Type 2 Diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care . 2010;33(12):e147–e167. doi:10.2337/dc10-9990 21115758
   PubMed Web of Science ®Google Scholar
• Keshel TE , Coker RH . Exercise Training and Insulin Resistance: a Current Review. J Obes Weight Loss Ther . 2015;5(5):S5–003.26523243
   PubMedGoogle Scholar
• Chiasson J-L . Early Insulin Use in Type 2 Diabetes: what are the cons? Diabetes Care . 2009;32(Suppl 2):S270–S274. doi:10.2337/dc09-S321 19875563
   PubMed Web of Science ®Google Scholar
• Taylor R . Type 2 Diabetes. Diabetes Care . 2013;36(4):1047. doi:10.2337/dc12-1805 23520370
   PubMed Web of Science ®Google Scholar
• Zhou X , Wu H , Long R , et al. Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation. J Nanobiotechnology . 2020;18(1):96. doi:10.1186/s12951-020-00652-z 32664978
   PubMed Web of Science ®Google Scholar
• Xiao Y , Tang Z , Wang J , et al. Oral Insulin Delivery Platforms: strategies To Address the Biological Barriers. Angewandte Chemie Int Edition . 2020;59(45):19787–19795. doi:10.1002/anie.202008879
   Web of Science ®Google Scholar
• Eldor ROY , Fleming GA , Neutel J , Homer KE , Kidron M , Rosenstock J . 105-LB: evening Oral Insulin (ORMD-0801) Glycemic Effects in Uncontrolled T2DM Patients. Diabetes . 2020;69(Supplement 1):105–LB. doi:10.2337/db20-105-LB
   Google Scholar
• Bahman F , Taurin S , Altayeb D , Taha S , Bakhiet M , Greish K . Oral Insulin Delivery Using Poly (Styrene Co-Maleic Acid) Micelles in a Diabetic Mouse Model. Pharmaceutics . 2020;12(11):1026. doi:10.3390/pharmaceutics12111026
   Web of Science ®Google Scholar
• Gallwitz B . The evolving place of incretin-based therapies in type 2 diabetes. Pediatric Nephrol . 2010;25(7):1207–1217. doi:10.1007/s00467-009-1435-z
   PubMed Web of Science ®Google Scholar
• Brunton S . GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? Int J Clin Pract . 2014;68(5):557–567. doi:10.1111/ijcp.12361 24499291
   PubMed Web of Science ®Google Scholar
• De Graaf C , Donnelly D , Wootten D , et al. Glucagon-Like Peptide-1 and Its Class B G Protein–Coupled Receptors: a Long March to Therapeutic Successes. Pharmacol Rev . 2016;68(4):954–1013. doi:10.1124/pr.115.011395 27630114
   PubMed Web of Science ®Google Scholar
• Holst JJ . The Physiology of Glucagon-like Peptide 1. Physiol Rev . 2007;87(4):1409–1439. doi:10.1152/physrev.00034.2006 17928588
   PubMed Web of Science ®Google Scholar
• Prasad-Reddy L , Isaacs D . A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context . 2015;4:212283. doi:10.7573/dic.212283 26213556
   PubMedGoogle Scholar
• Edavalath M , Stephens JW . Liraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives. Patient Prefer Adherence . 2010;4:61–68. doi:10.2147/ppa.s6358 20361006
   PubMed Web of Science ®Google Scholar
• Eng J , Kleinman W , Singh L , Singh G , Raufman J . Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem . 1992;267:7402–7405. doi:10.1016/S0021-9258(18)42531-8 1313797
   PubMed Web of Science ®Google Scholar
• Reed J , Bain S , Kanamarlapudi V . Recent advances in understanding the role of glucagon-like peptide 1 [version 1; peer review: 2 approved]. F1000Research . 2020;9:239. doi:10.12688/f1000research.20602.1
   Google Scholar
• Wang M , Yao P , Gao M , Jin J , Yu Y . Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites. RSC Adv . 2020;10(14):8044–8053. doi:10.1039/C9RA10593J
   Web of Science ®Google Scholar
• Reed J , Kanamarlapudi V . GLP-1. In: Choi S , editor. Encyclopedia of Signaling Molecules . Cham: Springer International Publishing; 2018:2098–2106.
   Google Scholar
• Trujillo JM , Nuffer W , Smith BA . GLP-1 receptor agonists: an updated review of head-to-head clinical studies. Ther Adv Endocrinol Metab . 2021;12:2042018821997320. doi:10.1177/2042018821997320 33767808
   PubMed Web of Science ®Google Scholar
• Seino Y , Fukushima M , Yabe D . GIP and GLP‐1, the two incretin hormones: similarities and differences. J Diabetes Investig . 2010;1(1–2):8–23. doi:10.1111/j.2040-1124.2010.00022.x
   PubMed Web of Science ®Google Scholar
• Levin PA , Nguyen H , Wittbrodt ET , Kim SC . Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research. Diabetes Metab Syndrome Obesity . 2017;10:123–139. doi:10.2147/DMSO.S130834
   PubMed Web of Science ®Google Scholar
• Potts JE , Gray LJ , Brady EM , Khunti K , Davies MJ , Bodicoat DH . The Effect of Glucagon-Like Peptide 1 Receptor Agonists on Weight Loss in Type 2 Diabetes: a Systematic Review and Mixed Treatment Comparison Meta-Analysis. PLoS One . 2015;10(6):e0126769. doi:10.1371/journal.pone.0126769 26121478
   PubMed Web of Science ®Google Scholar
• Tamura K , Minami K , Kudo M , Iemoto K , Takahashi H , Seino S . Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice. PLoS One . 2015;10(5):e0126003–e0126003. doi:10.1371/journal.pone.0126003 25938469
   PubMed Web of Science ®Google Scholar
• Garber AJ . Incretin effects on β-cell function, replication, and mass: the human perspective. Diabetes Care . 2011;34 Suppl 2(Suppl2):S258–S263. doi:10.2337/dc11-s230 21525465
   PubMed Web of Science ®Google Scholar
• Xu G , Kaneto H , Lopez-Avalos MD , Weir GC , Bonner-Weir S . GLP-1/exendin-4 facilitates β-cell neogenesis in rat and human pancreatic ducts. Diabetes Res Clin Pract . 2006;73(1):107–110. doi:10.1016/j.diabres.2005.11.007 16406191
   PubMed Web of Science ®Google Scholar
• Drucker DJ , Sherman SI , Gorelick FS , Bergenstal RM , Sherwin RS , Buse JB . Incretin-Based Therapies for the Treatment of Type 2 Diabetes: evaluation of the Risks and Benefits. Diabetes Care . 2010;33(2):428–433. doi:10.2337/dc09-1499 20103558
   PubMed Web of Science ®Google Scholar
• Nauck MA , Friedrich N . Do GLP-1–Based Therapies Increase Cancer Risk? Diabetes Care . 2013;36(Supplement 2):S245–S252. doi:10.2337/dcS13-2004 23882053
   PubMed Web of Science ®Google Scholar
• Finan B , Ma T , Ottaway N , et al. Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans. Sci Transl Med . 2013;5(209):209ra151–209ra151. doi:10.1126/scitranslmed.3007218
   PubMed Web of Science ®Google Scholar
• Patel V , Joharapurkar A , Kshirsagar S , et al. Coagonist of GLP-1 and glucagon decreases liver inflammation and atherosclerosis in dyslipidemic condition. Chem Biol Interact . 2018;282:13–21. doi:10.1016/j.cbi.2018.01.004 29325849
   PubMed Web of Science ®Google Scholar
• Wang A , Li T , An P , et al. Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway. PLoS One . 2017;12(1):e0169469. doi:10.1371/journal.pone.0169469 28122026
   PubMed Web of Science ®Google Scholar
• Lihn AS , Pedersen SB , Richelsen B . Adiponectin: action, regulation and association to insulin sensitivity. Obesity Rev . 2005;6(1):13–21. doi:10.1111/j.1467-789X.2005.00159.x
   PubMed Web of Science ®Google Scholar
• Tomkin GH . Treatment of type 2 diabetes, lifestyle, GLP1 agonists and DPP4 inhibitors. World J Diabetes . 2014;5(5):636–650. doi:10.4239/wjd.v5.i5.636 25317241
   PubMedGoogle Scholar
• Aroda VR . A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials. Diabetes Obes Metab . 2018;20(Suppl 1):22–33. doi:10.1111/dom.13162 29364586
   PubMed Web of Science ®Google Scholar
• Marso SP , Bain SC , Consoli A , et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Eng J Med . 2016;375(19):1834–1844. doi:10.1056/NEJMoa1607141
   PubMed Web of Science ®Google Scholar
• Marso SP , Daniels GH , Brown-Frandsen K , et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Eng J Med . 2016;375(4):311–322. doi:10.1056/NEJMoa1603827
   PubMed Web of Science ®Google Scholar
• Forst T , Matthias MW , Andreas P . Cardiovascular Benefits of GLP-1-Based Therapies in Patients with Diabetes Mellitus Type 2: effects on Endothelial and Vascular Dysfunction beyond Glycemic Control. Exp Diabetes Res . 2012;2012. doi:10.1155/2012/635472
   Google Scholar
• Holman RR , Bethel MA , Mentz RJ , et al. Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes. N Eng J Med . 2017;377(13):1228–1239. doi:10.1056/NEJMoa1612917
   PubMed Web of Science ®Google Scholar
• Pfeffer MA , Claggett B , Diaz R , et al. Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Eng J Med . 2015;373(23):2247–2257. doi:10.1056/NEJMoa1509225
   PubMed Web of Science ®Google Scholar
• Strain W , Griffiths J . A systematic review and meta-analysis of the impact of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiovascular outcomes in biologically healthy older adults. Br J Diabetes . 2021;21:30–35. doi:10.15277/bjd.2021.292
   Web of Science ®Google Scholar
• Karagiannis T , Tsapas A , Athanasiadou E , et al. GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract . 2021;174:108737. doi:10.1016/j.diabres.2021.108737 33705820
   PubMed Web of Science ®Google Scholar
• Marsico F , Paolillo S , Gargiulo P , et al. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials. Eur Heart J . 2020;41(35):3346–3358. doi:10.1093/eurheartj/ehaa082 32077924
   PubMed Web of Science ®Google Scholar
• Kristensen SL , Rørth R , Jhund PS , et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol . 2019;7(10):776–785. doi:10.1016/S2213-8587(19)30249-9 31422062
   PubMed Web of Science ®Google Scholar
• Knudsen LB , Kiel D , Teng M , et al. Small-molecule agonists for the glucagon-like peptide 1 receptor. Proc Natl Acad Sci U S A . 2007;104(3):937–942. doi:10.1073/pnas.0605701104 17213325
   PubMed Web of Science ®Google Scholar
• Irwin N , Flatt PR , Patterson S , Green BD . Insulin-releasing and metabolic effects of small molecule GLP-1 receptor agonist 6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline. Eur J Pharmacol . 2010;628(1–3):268–273. doi:10.1016/j.ejphar.2009.11.022 19917278
   PubMed Web of Science ®Google Scholar
• Sloop KW , Willard FS , Brenner MB , et al. Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets. Diabetes . 2010;59(12):3099. doi:10.2337/db10-0689 20823098
   PubMed Web of Science ®Google Scholar
• Nolte WM , Fortin J-P , Stevens BD , et al. A potentiator of orthosteric ligand activity at GLP-1R acts via covalent modification. Nat Chem Biol . 2014;10(8):629–631. doi:10.1038/nchembio.1581 24997604
   PubMed Web of Science ®Google Scholar
• Song G , Yang D , Wang Y , et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators. Nature . 2017;546:312. doi:10.1038/nature22378 28514449
   PubMed Web of Science ®Google Scholar
• Finan B , Yang B , Ottaway N , et al. A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents. Nat Med . 2015;21(1):27–36. doi:10.1038/nm.3761 25485909
   PubMed Web of Science ®Google Scholar
• Cui J , Shang A , Wang W , Chen W . Rational design of a GLP-1/GIP/Gcg receptor triagonist to correct hyperglycemia, obesity and diabetic nephropathy in rodent animals. Life Sci . 2020;260:118339. doi:10.1016/j.lfs.2020.118339 32841660
   PubMed Web of Science ®Google Scholar
• Elder KA , Wolfe BM . Bariatric Surgery: a Review of Procedures and Outcomes. Gastroenterology . 2007;132(6):2253–2271. doi:10.1053/j.gastro.2007.03.057 17498516
   PubMed Web of Science ®Google Scholar
• Eldar S , Heneghan HM , Brethauer SA , Schauer PR . Bariatric surgery for treatment of obesity. Int J Obes . 2011;35(S3):S16–S21. doi:10.1038/ijo.2011.142
   Web of Science ®Google Scholar
• Buchwald H , Williams SE . Bariatric Surgery Worldwide 2003. Obes Surg . 2004;14(9):1157–1164. doi:10.1381/0960892042387057 15527627
   PubMed Web of Science ®Google Scholar
• Singh AK , Singh R , Kota SK . Bariatric surgery and diabetes remission: who would have thought it? Indian J Endocrinol Metab . 2015;19(5):563–576. doi:10.4103/2230-8210.163113 26425464
   PubMedGoogle Scholar
• Brethauer SA , Aminian A , Romero-Talamás H , et al. Can Diabetes Be Surgically Cured?: long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus. Ann Surg . 2013;258(4):628–637. doi:10.1097/SLA.0b013e3182a5034b 24018646
   PubMed Web of Science ®Google Scholar
• Koliaki C , Liatis S , le Roux CW , Kokkinos A . The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord . 2017;17(1):50. doi:10.1186/s12902-017-0202-6 28797248
   PubMed Web of Science ®Google Scholar
• Shah A , Laferrère B . Diabetes after Bariatric Surgery. Can J Diabetes . 2017;41(4):401–406. doi:10.1016/j.jcjd.2016.12.009 28457649
   PubMed Web of Science ®Google Scholar
• Khalaf KI , Taegtmeyer H . Clues from Bariatric Surgery: reversing Insulin Resistance to Heal the Heart. Curr Diab Rep . 2013;13(2):245–251. doi:10.1007/s11892-013-0364-1 23354680
   PubMed Web of Science ®Google Scholar
• Provenzale D , Reinhold RB , Golner B , et al. Evidence for diminished B12 absorption after gastric bypass: oral supplementation does not prevent low plasma B12 levels in bypass patients. J Am Coll Nutr . 1992;11:29–35. doi:10.1080/07315724.1992.10718193 1541791
   PubMed Web of Science ®Google Scholar
• Halverson J . Micronutrient deficiencies after gastric bypass for morbid obesity. Am Surg . 1986;52:594–598.3777703
   PubMed Web of Science ®Google Scholar
• Avinoah EOA , Charuzi I . Nutritional status seven years after Roux-en-Y gastric bypass surgery. Surgery . 1992;111:137–142.1736382
   PubMed Web of Science ®Google Scholar
• Saliba W , El-Haddad B . Secondary Hyperparathyroidism: pathophysiology and Treatment. J Am Board Family Med . 2009;22(5):574–581. doi:10.3122/jabfm.2009.05.090026
   PubMed Web of Science ®Google Scholar
• Potts JT . Parathyroid hormone: past and present. J Endocrinol . 2005;187(3):311–325. doi:10.1677/joe.1.06057 16423810
   PubMed Web of Science ®Google Scholar
• Toh SY , Zarshenas N , Jorgensen J . Prevalence of nutrient deficiencies in bariatric patients. Nutrition . 2009;25(11):1150–1156. doi:10.1016/j.nut.2009.03.012 19487104
   PubMed Web of Science ®Google Scholar
• Reed J , Kanamarlapudi V , Bain S . Mechanism of cardiovascular disease benefit of glucagon-like peptide 1 agonists. Cardiovascular Endocrinol Metab . 2018;7(1):18–23.
   Web of Science ®Google Scholar
• Alicic RZ , Rooney MT , Tuttle KR . Diabetic Kidney Disease. Clin J Am Soc Nephrol . 2017;12(12):2032. doi:10.2215/CJN.11491116 28522654
   PubMed Web of Science ®Google Scholar
• Duh EJ , Sun JK , Stitt AW . Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight . 2017;2(14):e93751. doi:10.1172/jci.insight.93751
   PubMed Web of Science ®Google Scholar
• Leon BM , Maddox TM . Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes . 2015;6(13):1246–1258. doi:10.4239/wjd.v6.i13.1246 26468341
   PubMed Web of Science ®Google Scholar
• Tomita T . Apoptosis in pancreatic β-islet cells in Type 2 diabetes. Bosn J Basic Med Sci . 2016;16(3):162–179. doi:10.17305/bjbms.2016.919 27209071
   PubMed Web of Science ®Google Scholar
• Cho J-H , Kim J-W , Shin J-A , Shin J , Yoon K-H . β-cell mass in people with type 2 diabetes. J Diabetes Investig . 2011;2(1):6–17. doi:10.1111/j.2040-1124.2010.00072.x
   PubMed Web of Science ®Google Scholar
• le Roux CW , Astrup A , Fujioka K , et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet . 2017;389(10077):1399–1409. doi:10.1016/S0140-6736(17)30069-7 28237263
   PubMed Web of Science ®Google Scholar
• Jazayeri A , Rappas M , Brown AJH , et al. Corrigendum: crystal structure of the GLP-1 receptor bound to a peptide agonist. Nature . 2017;548:122. doi:10.1038/nature23311
   Web of Science ®Google Scholar
• Itariu BK , Stulnig TM . Autoimmune Aspects of Type 2 Diabetes Mellitus - A Mini-Review. Gerontology . 2014;60(3):189–196. doi:10.1159/000356747 24457898
   PubMed Web of Science ®Google Scholar
• Pietropaolo M , Barinas-Mitchell E , Pietropaolo SL , Kuller LH , Trucco M . Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes . 2000;49(1):32–38. doi:10.2337/diabetes.49.1.32 10615947
   PubMed Web of Science ®Google Scholar
• Brooks-Worrell BM , Reichow JL , Goel A , Ismail H , Palmer JP . Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients. Diabetes Care . 2011;34(1):168–173. doi:10.2337/dc10-0579 20855551
   PubMed Web of Science ®Google Scholar
• Haskell BDFK , Duffy TM , Sargent EE , Leiter EH . The diabetes-prone NZO/HlLt strain. I. Immunophenotypic comparison to the related NZB/BlNJ and NZW/LacJ strains. Lab Invest . 2002;82:833–842. doi:10.1097/01.LAB.0000018915.53257.00 12118085
   PubMed Web of Science ®Google Scholar
• Jagannathan M , McDonnell M , Liang Y , et al. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia . 2010;53(7):1461–1471. doi:10.1007/s00125-010-1730-z 20383694
   PubMed Web of Science ®Google Scholar
• Gandasi NR , Yin P , Omar-Hmeadi M , Ottosson laakso E , Vikman P , Glucose-Dependent Granule BS . Docking Limits Insulin Secretion and Is Decreased in Human Type 2 Diabetes. Cell Metab . 2018;27(2):470–478.e474. doi:10.1016/j.cmet.2017.12.017 29414688
   PubMed Web of Science ®Google Scholar
• Zhang Y , Chen W , Feng B , Cao H . The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: a Systematic Review and Meta-Analysis. Aging Dis . 2020;11(1):141–153. doi:10.14336/AD.2019.0421 32010488
   PubMed Web of Science ®Google Scholar
• El-Badawy A , El-Badri N . Clinical Efficacy of Stem Cell Therapy for Diabetes Mellitus: a Meta-Analysis. PLoS One . 2016;11(4):e0151938. doi:10.1371/journal.pone.0151938 27073927
   PubMed Web of Science ®Google Scholar
• Bhansali A , Upreti V , Khandelwal N , et al. Efficacy of autologous bone marrow-derived stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cells Dev . 2009;18(10):1407–1416. doi:10.1089/scd.2009.0164 19686048
   PubMed Web of Science ®Google Scholar
• D’Addio F , Valderrama Vasquez A , Ben Nasr M , et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis. Diabetes . 2014;63(9):3041–3046. doi:10.2337/db14-0295 24947362
   PubMed Web of Science ®Google Scholar
• Rahim F , Arjmand B , Shirbandi K , Payab M , Larijani B . Stem cell therapy for patients with diabetes: a systematic review and meta-analysis of metabolomics-based risks and benefits. Stem Cell Investig . 2018;5:40. doi:10.21037/sci.2018.11.01
   Google Scholar
• Bhansali S , Dutta P , Kumar V , et al. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: a Randomized, Placebo-Controlled Comparative Study. Stem Cells Dev . 2017;26(7):471–481. doi:10.1089/scd.2016.0275 28006991
   PubMed Web of Science ®Google Scholar
• World Health Organization. Body Mass Index (BMI). Available from: https://www.who.int/data/gho/data/themes/theme-details/GHO/body-mass-index-(bmi)?introPage=intro_3.html. Accessed August 03, 2021.
   Google Scholar
• Dimitriadis G , Mitrou P , Lambadiari V , Maratou E , Raptis SA . Insulin effects in muscle and adipose tissue. Diabetes Res Clin Pract . 2011;93:S52–S59. doi:10.1016/S0168-8227(11)70014-6 21864752
   PubMed Web of Science ®Google Scholar
• Huang S , Czech MP . The GLUT4 Glucose Transporter. Cell Metab . 2007;5(4):237–252. doi:10.1016/j.cmet.2007.03.006 17403369
   PubMed Web of Science ®Google Scholar
• Steiner DJ , Kim A , Miller K , Hara M . Pancreatic islet plasticity: interspecies comparison of islet architecture and composition. Islets . 2010;2(3):135–145. doi:10.4161/isl.2.3.11815 20657742
   PubMed Web of Science ®Google Scholar
• Henquin J-C . The dual control of insulin secretion by glucose involves triggering and amplifying pathways in beta-cells. Diabetes Res Clin Pract . 2011;93:S27–S31. doi:10.1016/S0168-8227(11)70010-9 21864748
   PubMed Web of Science ®Google Scholar
• Mailloux RJ , Harper M-E . Mitochondrial proticity and ROS signaling: lessons from the uncoupling proteins. Trends Endocrinol Metab . 2012;23(9):451–458. doi:10.1016/j.tem.2012.04.004 22591987
   PubMed Web of Science ®Google Scholar
• Reed J , Kanamarlapudi V . GLP-1R. In: Choi S , editor. Encyclopedia of Signaling Molecules . New York: Springer New York; 2017:2106–2117.
   Google Scholar
• Lorenz M , Evers A , Wagner M . Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity. Bioorg Med Chem Lett . 2013;23(14):4011–4018. doi:10.1016/j.bmcl.2013.05.022 23743288
   PubMed Web of Science ®Google Scholar